Reading CF? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CF free→Reading CF? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CF free→
NYSEMaterialsAgricultural InputsSnapshot 2026-06-12
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is strong, but management's recent track record has been unsteady, with frequent disruptive corporate changes. Earnings quality is mixed, and risk is elevated, while the sector backdrop is a headwind. Peer multiples imply a price about 60% above where it trades (it looks cheap on this basis); the read is cheap, quality intact. The outlook hinges on whether CF cuts guidance on the next call, which could negatively impact estimates. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 6 valuation methods, at three horizons. Current price $109.48. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $109 CF trades at 10× p/e, below its 25× p/e peer median. Our $276 fair value sits above the price; low confidence. Analysts: $85–$145. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 60% below a flat-multiple fair value, below our forecast of about 1%. This describes what's priced in, not a forecast of the move.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Crisis) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Materials names rated strong grew net income 63% of the time over the next year (vs 54% for the rest of the cohort, n=1093).
Over the trailing year it converted 1.25x of net income into operating cash flow. Historically, Materials names rated neutral grew net income 52% of the time over the next year (vs 55% for the rest of the cohort, n=1297).
Most sensitive to long-term interest rates.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, the broad stock market, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $3.98 → $5.91 (+48.5% / 30d). 4 raised, 1 cut, 5 covering analysts.
0 upgrades, 0 downgrades / 30d, 1 maintained. 23% of analysts rate Buy.
Market and fundamentals agree. Analysts are positioned bullishly on a fundamentally strong name.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$223.
How much price usually moves either way.
On a bad day, this stock has moved -$384.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $2,488.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Watching how much money is spent on this project is important for CF's growth.
Confirms:Management says Blue Point JV spending is on track or has been cut.
Disproves:Management reports big cost overruns or delays in Blue Point JV spending.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for CF yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition. On May 7, 2026, CF Industries Holdings, Inc. will host a conference call discussing its results for the quarter ended March 31, 2026, at which the presentation attached hereto as Exhibit 99.1 will be used. The information set forth herein, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing u…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$85.00 – $145.00 (median $115.00) · 11 analysts · as of 2026-05-11
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Materials (broad).
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
CF CF Industries | Above typical Show detailsSector percentile: 98 of 100 | inexpensive | elevated |
LIN Linde plc | Typical Show detailsSector percentile: 67 of 100 | expensive | moderate |
NEM Newmont | Above typical Show detailsSector percentile: 94 of 100 | inexpensive | elevated |
FCX Freeport-McMoRan | Typical Show detailsSector percentile: 51 of 100 | full | elevated |
SHW Sherwin-Williams | Above typical Show detailsSector percentile: 71 of 100 | full | moderate |
7 material management or governance events in the past 24 months, led by executive changes. Historically, Materials names rated volatile grew net income 61% of the time over the next year (vs 51% for the rest of the cohort, n=235).
Not investment advice. As of 2026-06-12.
via XLB
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
CF Industries aims to maintain its capital expenditures guidance for the year 2026.
CF Industries is focusing on capital expenditures related to the Blue Point joint venture.
CF Industries aimed to achieve $2 billion in free cash flow for the year 2025.
Why it matters: Changes in supply and demand can greatly affect prices and sales for CF Industries.
Confirms one read:Global nitrogen supply and demand are tightening, which can raise prices.
Confirms the other:The global supply and demand for nitrogen are getting better. This is causing prices to drop.
Why it matters: Updates on Blue Point JV CAPEX will show commitment to strategic projects. Delays could hurt growth.
Confirms:Management will share good news about Blue Point JV CAPEX plans in future calls.
Disproves:There will be no updates or bad news about Blue Point JV CAPEX soon.
Why it matters: Higher natural gas costs could lower profits.
Confirms:Natural gas prices are below $4.57 per MMBtu, helping to keep costs down.
Disproves:Natural gas prices rise above $4.57 per MMBtu, increasing production costs.
Why it matters: Achieving the $2B free cash flow target is vital for CF's financial health and growth strategy.
Confirms:Management says they are making progress toward the $2B free cash flow goal.
Disproves:Management revises down the $2B free cash flow target for 2025.
Results of Operations and Financial Condition. On May 6, 2026, CF Industries Holdings, Inc. issued a press release announcing its results for the quarter ended March 31, 2026. The press release is attached hereto as Exhibit 99.1. The information set forth herein, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act…
executive vice president and chief financial officer — Andrew T. Scribner: CF Industries hired a new CFO from an external company.
Regulation FD Disclosure On March 15, 2026, CF Industries Sales, LLC and CF Industries Nitrogen LLC, both subsidiaries of CF Industries Holdings, Inc. (collectively, the “Company”) signed an agreement to settle litigation with Orica International Pte Ltd and certain other affiliates of Orica Ltd. (“Orica”) and Nelson Brothers, Inc. and Nelson Brothers LLC (“Nelson Brothers”). In connection with the resolution of the litigation pursuant to the settlement, Orica has agreed to pay the Company $1…
Results of Operations and Financial Condition. On February 19, 2026, CF Industries Holdings, Inc. will host a conference call discussing its results for the quarter and year ended December 31, 2025, at which the presentation attached hereto as Exhibit 99.1 will be used. The information set forth herein, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by referen…